- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News 1193 results
Press Release
January 15, 2025
Lauren Roth, Former Leader of FDA’s Office of Policy, Joins King & Spalding’s FDA and Life Sciences Team
Press Release
January 14, 2025
U.S. Department of Commerce Trade Official Ryan Majerus Joins King & Spalding’s International Trade Team
Press Release
January 13, 2025
Former U.S. State Department Official and Google Lawyer Nema Milaninia Joins King & Spalding as Partner in Washington, D.C.
Cases & Deals
Cases & Deals
December 18, 2024
King & Spalding Successfully Represents Pro Bono Client and Environmentalist Paul Watson In Extradition Case
In the News · Source: Law360 Healthcare Authority
December 17, 2024
Lisa Dwyer discuses FDA untitled letter trends regarding drug advertising and promotion
In the News · Source: The Dairy Download
December 13, 2024
Steve Orava discusses the current trade outlook and opportunities for growth for the dairy industry under the incoming administration and new Congress
In the News · Source: Corporate Compliance Insights
December 11, 2024
K&S's Client Alerts are referenced in Corporate Compliance Insights’ round-up of the top stories of 2024
Recognition
December 11, 2024
King & Spalding Again Recognized on Global Competition Review’s GCR 100 List
Press Release
December 10, 2024
King & Spalding Elects 37 New Partners and Five Counsel in Record Promotion Round
In the News · Source: The American Lawyer
Recognition
December 10, 2024
Financial Times Honors King & Spalding with its Innovation in Digital Legal Products Award